What is the appropriate evaluation and management for a patient with an unknown‑cause cough lasting several days and a normal chest X‑ray?

Evaluation and Management of Chronic Cough with Normal Chest X-ray

For a patient with chronic cough (lasting >8 weeks) and a normal chest X-ray, you should proceed with a systematic protocol-based evaluation including objective testing for bronchial hyperresponsiveness and eosinophilic bronchitis, followed by empiric therapeutic trials targeting the three most common causes: upper airway cough syndrome, asthma, and gastroesophageal reflux disease 1, 2.

Important Clarification About Your Case

Your patient has a cough lasting "four days" - this is an acute cough, not chronic cough. The evidence-based guidelines I'm providing apply to chronic cough (>8 weeks in adults). For a 4-day cough with normal chest X-ray, observation and symptomatic treatment are typically appropriate unless red flags are present. However, I'll provide the full chronic cough algorithm below as it appears you may be asking about longer-duration cough management.

Initial Diagnostic Workup

After obtaining a normal chest X-ray, complete these tests 1, 3:

• Spirometry with bronchodilator testing - to assess for asthma/COPD
• Exhaled nitric oxide measurement or sputum eosinophil count - to detect eosinophilic bronchitis
• Blood eosinophil count
• Validated cough severity and quality of life questionnaires - to establish baseline and monitor response

Medication Review (Critical First Step)

Immediately discontinue ACE inhibitors if the patient is taking one - switch to an alternative antihypertensive from a different drug class and observe for 4 weeks 4, 3. ACE inhibitor-induced cough can persist for weeks after discontinuation. Also check for sitagliptin use 4.

Empiric Treatment Algorithm

Target the three most common causes sequentially or simultaneously based on clinical suspicion 1, 4:

1. Upper Airway Cough Syndrome (formerly postnasal drip)

• First-generation antihistamine + decongestant combination
• Treat for 4-6 weeks before declaring treatment failure
• Look for: nasal discharge, throat clearing, sensation of postnasal drip

2. Asthma/Eosinophilic Bronchitis

• Inhaled corticosteroids ± bronchodilators
• Consider this even without wheezing on exam
• Objective testing (spirometry, bronchial hyperresponsiveness testing) should guide this decision 1
• Important caveat: Do NOT prescribe inhaled corticosteroids if tests for bronchial hyperresponsiveness AND eosinophilia are both negative 1

3. Gastroesophageal Reflux Disease

• Proton pump inhibitor therapy PLUS lifestyle modifications (not PPI alone)
• Treatment must include more than just acid suppression 4
• Critical caveat: Do NOT prescribe PPI therapy if the patient has a negative workup for acid reflux 1
• Consider physiologic testing for refractory cases

Key Management Principles

Maintain all partially effective treatments - chronic cough frequently has multiple simultaneous causes 4. If a treatment provides partial improvement, continue it while addressing other potential etiologies.

Schedule follow-up in 4-6 weeks to assess treatment response using validated cough severity measures 4, 3.

Optimize each therapy before declaring failure - ensure proper inhaler technique, medication adherence, and adequate treatment duration 1.

Red Flags Requiring Immediate Further Investigation

Proceed directly to additional testing or specialist referral if any of these are present 4:

• Hemoptysis
• Smoker >45 years with new or changed cough
• Prominent dyspnea at rest or night
• Systemic symptoms (fever, weight loss)
• Hoarseness or voice changes
• Recurrent pneumonia
• Trouble swallowing

When Initial Evaluation Fails

If the cough persists after 4-6 weeks of optimized empiric therapy with confirmed patient adherence, the patient has unexplained chronic cough 1. At this point:

Treatment Options for Unexplained Chronic Cough

1. Speech pathology-based multimodality cough suppression therapy (Grade 2C recommendation) 1

2. Gabapentin trial (Grade 2C recommendation) 1:

   • Start 300 mg once daily
   • Titrate up daily as tolerated
   • Maximum dose: 1,800 mg/day in two divided doses
   • Discuss side effects and risk-benefit profile before starting
   • Reassess risk-benefit at 6 months before continuing
   • This improves quality of life even when cough frequency doesn't change

3. Referral to specialized cough clinic 1, 4

What NOT to Do for Unexplained Chronic Cough

• Do NOT prescribe inhaled corticosteroids if bronchial hyperresponsiveness and eosinophilia testing are negative 1
• Do NOT prescribe PPI therapy if acid reflux workup is negative 1

Common Pitfalls to Avoid

Incomplete investigation masquerading as unexplained cough - The guidelines emphasize that many cases of "unexplained" cough are actually inadequately investigated or inadequately treated 1. Before labeling cough as unexplained, ensure:

• Objective testing for asthma/eosinophilic bronchitis was performed (not just empiric treatment)
• Treatment trials were optimal in dose and duration
• Patient adherence was confirmed
• Environmental and occupational exposures were assessed

Premature advanced testing - The 2021 ACR guidelines note that chest CT and other advanced imaging should be reserved for cases with red flags or failed empiric therapy 2. The diagnostic yield is low in patients with normal chest X-rays who haven't undergone systematic empiric treatment.

Ignoring quality of life impact - Chronic cough significantly impairs quality of life 1. Use validated instruments to measure this, as it guides treatment decisions, particularly for therapies like gabapentin where the primary benefit is quality of life improvement rather than cough frequency reduction.